CVS Health Co. (NYSE:CVS) Shares Sold by Vicus Capital

Vicus Capital trimmed its position in CVS Health Co. (NYSE:CVS) by 18.5% in the second quarter, HoldingsChannel.com reports. The firm owned 5,162 shares of the pharmacy operator’s stock after selling 1,168 shares during the quarter. Vicus Capital’s holdings in CVS Health were worth $305,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. International Assets Investment Management LLC boosted its position in shares of CVS Health by 11.4% during the 4th quarter. International Assets Investment Management LLC now owns 16,744 shares of the pharmacy operator’s stock valued at $1,322,000 after purchasing an additional 1,715 shares in the last quarter. Tennessee Valley Asset Management Partners acquired a new position in CVS Health in the fourth quarter worth approximately $50,000. CWM LLC increased its holdings in shares of CVS Health by 1.6% in the fourth quarter. CWM LLC now owns 72,073 shares of the pharmacy operator’s stock valued at $5,691,000 after buying an additional 1,168 shares in the last quarter. Handelsbanken Fonder AB lifted its position in shares of CVS Health by 14.3% during the 4th quarter. Handelsbanken Fonder AB now owns 557,756 shares of the pharmacy operator’s stock valued at $44,040,000 after acquiring an additional 69,594 shares during the last quarter. Finally, Commerzbank Aktiengesellschaft FI bought a new stake in shares of CVS Health during the 4th quarter worth $463,000. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Stock Down 1.4 %

NYSE CVS traded down $0.81 during trading on Thursday, hitting $57.51. 1,781,090 shares of the company traded hands, compared to its average volume of 11,261,861. The company has a market capitalization of $72.20 billion, a P/E ratio of 10.18, a PEG ratio of 0.57 and a beta of 0.52. The business has a fifty day simple moving average of $58.96 and a 200 day simple moving average of $65.29. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25. The company has a current ratio of 0.81, a quick ratio of 0.61 and a debt-to-equity ratio of 0.78.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a return on equity of 13.53% and a net margin of 2.03%. The firm had revenue of $91.23 billion during the quarter, compared to analysts’ expectations of $91.41 billion. During the same quarter in the prior year, the business earned $2.21 earnings per share. The company’s revenue was up 2.6% on a year-over-year basis. As a group, sell-side analysts predict that CVS Health Co. will post 7 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Stockholders of record on Monday, July 22nd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.63%. The ex-dividend date was Monday, July 22nd. CVS Health’s dividend payout ratio is currently 46.75%.

Analyst Ratings Changes

CVS has been the topic of a number of recent analyst reports. Leerink Partnrs lowered CVS Health from an “outperform” rating to a “market perform” rating in a research report on Wednesday, May 1st. Barclays decreased their target price on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a report on Thursday, August 8th. UBS Group lowered shares of CVS Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $85.00 to $60.00 in a report on Thursday, May 2nd. Mizuho lowered their price objective on shares of CVS Health from $86.00 to $72.00 and set a “buy” rating on the stock in a research report on Thursday, May 2nd. Finally, Evercore ISI cut their target price on shares of CVS Health from $65.00 to $62.00 and set an “outperform” rating on the stock in a research note on Thursday, August 8th. Eleven equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $73.24.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.